Shah, V. N., Franek, E., Wernicke-Panten, K., Pierre, S., Mukherjee, B., & Sadeharju, K. (2021). Efficacy, Safety, and Immunogenicity of Insulin Aspart Biosimilar SAR341402 Compared with Originator Insulin Aspart in Adults with Diabetes (GEMELLI 1): A Subgroup Analysis by Prior Type of Mealtime Insulin. Diabetes Ther.

Shah, Viral N., Edward Franek, Karin Wernicke-Panten, Suzanne Pierre, Bhaswati Mukherjee, ja Karita Sadeharju. "Efficacy, Safety, and Immunogenicity of Insulin Aspart Biosimilar SAR341402 Compared With Originator Insulin Aspart in Adults With Diabetes (GEMELLI 1): A Subgroup Analysis By Prior Type of Mealtime Insulin." Diabetes Ther 2021.

Shah, Viral N., et al. "Efficacy, Safety, and Immunogenicity of Insulin Aspart Biosimilar SAR341402 Compared With Originator Insulin Aspart in Adults With Diabetes (GEMELLI 1): A Subgroup Analysis By Prior Type of Mealtime Insulin." Diabetes Ther 2021.